
|
New
U.S. HIV-Prevention Program to Target Those Already Infected
[McCarthy M. Lancet 2001;357:613]: This
is a brief report in Lancet concerning the announcement of
a "major shift in strategy," in an attempt to reduce the
incidence of HIV infection by 50% (from 40,000 to 20,000 infections
per year) over the next five years. The new strategy is the "Serostatus
Approach to Fighting the HIV Epidemic" (SAFE) to be run by
the CDC. The previous focus was on educating persons at high-risk.
The new program will deal with those who are already infected and
will include an attempt to identify the estimated one-third of patients
who have HIV infection and have not been tested. The hope is that
the number of infected patients who are aware of their HIV infection
will increase from 70% to 95% by the year 2005, and this will foster
transmission reduction through counseling and antiviral therapy
to reduce infectivity.
Comment: Many will view this as a long overdue shift in emphasis
by the CDC. The policy shift comes at the time the IOM has been
highly critical of the U.S. prevention efforts. The IOM identified
three areas that needed emphasis: realistic sex education in schools,
support for needle exchange as the most cost-effective HIV prevention
method, and adequate reimbursement for counseling. It is not yet
clear how these strategies will be incorporated in the SAFE program.
With regard to case detection, the effort will be notably enhanced
with the availability of rapid tests, particularly those that can
be provider read, are inexpensive, and use non-blood specimens such
as saliva. This technology is currently under review by the FDA.
posted
3/8/2001

|

|